Bio Essence

Bio Essence Capital Intensity

The Capital Intensity Ratio of Bio Essence (BIOE) as of Oct 28, 2026 is 22.26 %. In the previous year, Capital Intensity Ratio was 86.75 % — a change of -74.34% (lower).

Capital Intensity

22.26 %

YoY

-74.34%

Last updated:

Capital Intensity Ratio of Bio Essence is 2025 22.26 % . Capital Intensity Ratio of Bio Essence was 2024 86.75 % . It decreases by -74.34% lower compared to the previous year.

The Bio Essence Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2018
103.83 USD
Jan 1, 2019
277.71 USD
Jan 1, 2020
192.50 USD
Jan 1, 2021
191.36 USD
Jan 1, 2022
248.99 USD
Jan 1, 2023
482.64 USD
Jan 1, 2024
86.75 USD
Jan 1, 2025
22.26 USD
The Bio Essence Capital Intensity history
YEARCapital IntensityYoY
22.26 %-74.34%
86.75 %-82.03%
482.64 %+93.83%
248.99 %+30.12%
191.36 %-0.59%
192.50 %-30.68%
277.71 %+167.47%
103.83 %-26.30%
140.88 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio Essence Stock analysis

What does Bio Essence do? Bio Essence Corp. generates revenue through its three subsidiaries: Bio Essence Pharmaceutical (BEP), which operates as a health supplement original equipment manufacturer (OEM) service provider; Bio Essence Herbal Essentials (BEH), which targets healthcare practitioners with herbal products including granules, capsules, pills, and tablets, and offers special formulation services; and McBE Pharma (McBE), which develops, manufactures, and sells prescription drugs. The company's products are sold directly to healthcare practitioners such as dietitians and nutraceutical practitioners, who then recommend them to their patients. BEH specifically serves practitioners in the integrative healthcare market, providing both standard and custom-formulated herbal supplements. BEP functions as an OEM for health supplement manufacturers, producing private-label products under other brands. McBE Pharma focuses on prescription drugs, targeting healthcare providers for direct sales. The firm's direct connections with practitioners enable it to reach end consumers through professional recommendations rather than retail channels. Bio Essence Herbal Essentials Inc. (BEH) emphasizes its role in connecting practitioners with patients through tailored herbal supplement solutions. The company's revenue streams are derived from the sale of herbal health supplements, vitamin nutritional supplements, and prescription drugs. BEH's target segment includes practitioners who specialize in integrative healthcare, such as dietitians and nutraceutical practitioners, who use the company's products to support patient care. McBE Pharma's segment consists of healthcare providers seeking prescription drug solutions for their patients. BEP serves as a manufacturing partner for other supplement brands, supplying OEM services. Bio Essence is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio Essence stock

Capital Intensity Ratio of Bio Essence is 22.26 % in 2025.

Capital Intensity Ratio of Bio Essence changed from 86.75 % to 22.26 %, representing a -74.34% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio Bio Essence since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's Bio Essence with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Bio Essence

All Key Metrics — Bio Essence